Politician trade (House)

Cytokinetics (CYTK): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Cytokinetics in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
2 days
Disclosure lag
Traded
Jun 30, 2026
Disclosed
Jul 2, 2026

What stands out in this filing

  • CYTK closed at $85.19 on Jun 30, 2026, within 3% of its 52-week high, after a 12% rise over the previous 30 trading days.
  • Disclosed 2 days after the trade.
  • Owner named on the report: Filer.
  • 2 disclosures on CYTK by this member on file.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 1, 2026InsiderOfficer sold ~$1.03M of CYTK shares in the open market
  2. May 5, 2026Company filing · Form 8-K · ResultsReported its results
  3. May 5, 2026Insider · 5 peopleInsiders: 5 sales (~$4.8M)
  4. May 14, 2026InsiderCEO sold ~$584K of CYTK shares in the open market
  5. May 19, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
  6. May 27, 2026InsiderCEO sold ~$579K of CYTK shares in the open market
  7. Jun 1, 2026Insider · 3 peopleInsiders: 3 sales (~$1.7M)
  8. Jun 9, 2026InsiderOfficer sold ~$238K of CYTK shares in the open market
  9. Jun 15, 2026InsiderCEO sold ~$528K of CYTK shares in the open market
  10. Jun 23, 2026InsiderOfficer sold ~$278K of CYTK shares in the open market
  11. Jun 24, 2026InsiderCFO sold ~$3.19M of CYTK shares in the open market
  12. Jun 29, 2026InsiderCFO sold ~$266K of CYTK shares in the open market
  13. Jun 30, 2026 · this disclosureCongressDisclosed purchase of CYTK — reported range $1,001 - $15,000

What came next

  1. Jul 1, 2026Insider · 3 peopleInsiders: 3 sales (~$2.0M)
  2. Jul 7, 2026InsiderOfficer sold ~$303K of CYTK shares in the open market
  3. Jul 13, 2026Insider · 1 personInsiders: 2 sales (~$615K)
  4. Jul 21, 2026InsiderOfficer sold ~$282K of CYTK shares in the open market
  5. Jul 27, 2026InsiderCEO sold ~$607K of CYTK shares in the open market
  6. Jul 30, 2026InsiderOfficer sold ~$1.12M of CYTK shares in the open market
  7. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  8. Aug 10, 2026InsiderCEO sold ~$576K of CYTK shares in the open market
  9. Aug 18, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
  10. Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  11. Sep 1, 2026InsiderDirector sold ~$357K of CYTK shares in the open market
  12. Sep 8, 2026InsiderOfficer sold ~$264K of CYTK shares in the open market
  13. Sep 11, 2026InsiderDirector sold ~$75K of CYTK shares in the open market
  14. Sep 14, 2026InsiderCEO sold ~$551K of CYTK shares in the open market
  15. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$6.9M)
  16. Sep 22, 2026InsiderOfficer sold ~$239K of CYTK shares in the open market
  17. Sep 28, 2026InsiderCEO sold ~$491K of CYTK shares in the open market
  18. Sep 29, 2026CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
  19. Oct 6, 2026InsiderOfficer sold ~$215K of CYTK shares in the open market
  20. Oct 12, 2026InsiderCEO sold ~$472K of CYTK shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 26 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)

The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Cytokinetics (CYTK) stock, and how much?

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Cytokinetics in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Jun 30, 2026. Disclosed: Jul 2, 2026. That is 2 days between the two dates.

What stands out in this filing?

CYTK closed at $85.19 on Jun 30, 2026, within 3% of its 52-week high, after a 12% rise over the previous 30 trading days. Disclosed 2 days after the trade. Owner named on the report: Filer.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cytokinetics recently?

For Cytokinetics, OQRO holds 26 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days. They are listed on the CYTK page.

Does this mean CYTK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data